✦ LIBER ✦

Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: a comparative analysis of response to treatment and predictors of outcome

✍ Scribed by Giulio Fortuna; Elvira Ruoppo; Annamaria Pollio; Massimo Aria; Daniela Adamo; Stefania Leuci; Giovanni Dell’Aversana Orabona; Michele D. Mignogna

Book ID: 111255554
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 180 KB
Volume: 41
Category: Article
ISSN: 0904-2512
DOI: 10.1111/j.1600-0714.2011.01095.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous Bisphosphonate Therapy may L

Intravenous Bisphosphonate Therapy may Lead to Osteonecrosis of the Jaw in Multiple Myeloma, Breast, and Prostate Cancer Patients

✍ Cesar A. Migliorati 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Incidence of Osteonecrosis of the Jaw in

Incidence of Osteonecrosis of the Jaw in Patients With Multiple Myeloma and Breast or Prostate Cancer on Intravenous Bisphosphonate Therapy

✍ Estee P. Wang; Leonard B. Kaban; Gordon J. Strewler; Noopur Raje; Maria J. Troul 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 380 KB

Incidence and outcomes of osteonecrosis

Incidence and outcomes of osteonecrosis of the jaw from an integrated analysis of three pivotal randomized double-blind, double-dummy phase 3 trials comparing denosumab and zoledronic acid for treatment of bone metastases in advanced cancer patients or myeloma

✍ J.E. Brown*; C.H. Barrios; I.J. Diel; T. Facon; K. Fizazi; T. Ibrahim; F. Saad; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Authors’ response to the letter to the E

Authors’ response to the letter to the Editor from Drs. Kyridis and Triaridis regarding ‘Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients’

✍ Stephen T. Sonis; Brynmor A. Watkins; Gregory D. Lyng; Mark A. Lerman; Kenneth C 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Treatment of Bendamustine and Prednisone

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

✍ W. Pönisch; P. S. Mitrou; K. Merkle; M. Herold; M. Assmann; G. Wilhelm; K. Dachs 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 344 KB